Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
41
FCNCA Quote, Financials, Valuation and Earnings
Last price:
$1,920.30
Seasonality move
:
4.45%
Day range:
$1,917.10 - $1,941.29
52-week range:
$1,473.62 - $2,412.93
Dividend yield:
0.37%
P/E ratio:
11.10x
P/S ratio:
2.87x
P/B ratio:
1.20x
Volume:
42.4K
Avg. volume:
91K
1-year change:
8.78%
Market cap:
$25.8B
Revenue:
$9.7B
EPS (TTM):
$174.64
Analysts' Opinion
-
Consensus RatingFirst Citizens BancShares has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 4 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2,198.85, First Citizens BancShares has an estimated upside of 13.47% from its current price of $1,918.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1,900.00 representing 1.95% downside risk from its current price of $1,918.20.
Fair Value
-
According to the consensus of 8 analysts, First Citizens BancShares has 13.47% upside to fair value with a price target of $2,198.85 per share.
FCNCA vs. S&P 500
-
Over the past 5 trading days, First Citizens BancShares has underperformed the S&P 500 by -1.32% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
First Citizens BancShares does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
First Citizens BancShares revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter First Citizens BancShares reported revenues of $2.3B.
Earnings Growth
-
First Citizens BancShares earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter First Citizens BancShares reported earnings per share of $34.47.
Enterprise value:
29.5B
EV / Invested capital:
0.49x
Price / LTM sales:
2.87x
EV / EBIT:
3.51x
EV / Revenue:
3.10x
PEG ratio (5yr expected):
--
EV / Free cash flow:
26.77x
Price / Operating cash flow:
24.80x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
1.14%
Net Income Margin (TTM):
26.54%
Return On Equity:
11.32%
Return On Invested Capital:
4.25%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4.8B | $10.1B | $9.5B | $2.4B | $2.3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $704.45 | $180.13 | $174.64 | $49.26 | $34.47 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $15.5B | $21.3B | $53.1B | $60.6B | $42.1B | |
| Total Assets | $53.9B | $108.6B | $214.7B | $217.8B | $228.8B | |
| Current Liabilities | $680.7M | $616M | $1B | $1.1B | $557M | |
| Total Liabilities | $49.6B | $98B | $195.4B | $196B | $206.5B | |
| Total Equity | $4.3B | $10.6B | $19.2B | $21.8B | $22.3B | |
| Total Debt | $1.2B | $2.7B | $45.6B | $37.1B | $37.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.9B | $3.5B | $2.6B | $461M | $98M | |
| Cash From Investing | $508M | -$4.5B | -$10.7B | -$4.3B | -$4.9B | |
| Cash From Financing | -$1.3B | $107M | $8.2B | $3.6B | $4.8B | |
| Free Cash Flow | $835M | $2.1B | $1.1B | $176M | -$175M | |
FCNCA
Sector
Market Cap
$25.8B
$628.1M
Price % of 52-Week High
80.31%
87.3%
Dividend Yield
0.37%
1.97%
Shareholder Yield
--
4.02%
1-Year Price Total Return
9.63%
9.14%
Beta (5-Year)
0.639
0.587
Dividend yield:
0.37%
Annualized payout:
$6.87
Payout ratio:
6.37%
Growth streak:
8 years
Technicals
8-day SMA
Sell
Level
$1,934.51
200-day SMA
Sell
Level
$1,992.31
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$1,850.96
Relative Strength Index (RSI14)
Buy
Level
59.23
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-17.7503
50-day SMA
Buy
Level
$1,796.09
MACD (12, 26)
Buy
Level
45.90
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7038)
Sell
CA Score
(Annual)
Level (-2.1063)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (2.0622)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.
Stock Forecast FAQ
In the current month, FCNCA has received 4 Buy ratings 4 Hold ratings, and 0 Sell ratings. The FCNCA average analyst price target in the past 3 months is $2,198.85.
-
Where Will First Citizens BancShares Stock Be In 1 Year?
According to analysts, the consensus estimate is that First Citizens BancShares share price will rise to $2,198.85 per share over the next 12 months.
-
What Do Analysts Say About First Citizens BancShares?
Analysts are divided on their view about First Citizens BancShares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that First Citizens BancShares is a Sell and believe this share price will drop from its current level to $1,900.00.
-
What Is First Citizens BancShares's Price Target?
The price target for First Citizens BancShares over the next 1-year time period is forecast to be $2,198.85 according to 8 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is FCNCA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for First Citizens BancShares is a Leans Bullish. 4 of 8 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of FCNCA?
You can purchase shares of First Citizens BancShares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase First Citizens BancShares shares.
-
What Is The First Citizens BancShares Share Price Today?
First Citizens BancShares was last trading at $1,920.30 per share. This represents the most recent stock quote for First Citizens BancShares. Yesterday, First Citizens BancShares closed at $1,918.20 per share.
-
How To Buy First Citizens BancShares Stock Online?
In order to purchase First Citizens BancShares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
52
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 24.59% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is up 22.13% over the past day.
